News for Ituran Location and Control Ltd. (ITRN)

Ituran is showing strong revenue growth and strategic partnerships despite market fluctuations. See why I downgrade ITRN stock from buy to hold.

I initially rated Ituran Location and Control Ltd. (ITRN) as undervalued by about 1/3, predicting growth from new strategic partnerships. See my current rating.

Shares of Ituran Location and Control Ltd (ITRN) surged 2.43% in mid-day trading on Feb 14. The stock reached an intraday high of $36.09, before settling at $

Ituran stock hits 52-week high at $33.1 amid robust growth

PR NewswireAZOUR, Israel, Jan. 9, 2025 Will attend and meet investors at the Needham growth conference on Tuesday, January 14 and the Freedom Israel Opport

Ituran stock hits 52-week high at $31.65 amid robust growth

Shares of Ituran Location and Control Ltd (ITRN) surged 4.36% in mid-day trading on Jan 1. The stock reached an intraday high of $31.15, up from its previous

PR NewswireAZOUR, Israel, Dec. 4, 2024 AZOUR, Israel, Dec. 4, 2024 /PRNewswire/ -- Ituran Location and Control Ltd. (Nasdaq: ITRN) announced that its joint

Shares of Ituran Location and Control Ltd (ITRN) surged 3.88% in mid-day trading on Nov 29. The stock reached an intraday high of $30.97, before settling at $

Revenue: $83.5 million, a 3% increase year-over-year.Subscription Fees Revenue: $59.6 million, a 1% decrease year-over-year.Product Revenue: $23.9 million, a 1

Nov 21, 2024 / 03:00PM GMTOperator Ladies and gentlemen, thank you for standing by. Welcome to the Ituran third quarter of 2024 results conference call. (Operat

Ituran Location and Control Ltd. (NASDAQ:ITRN) Q3 2024 Earnings Conference Call November 21, 2024 10:00 AM ETCompany ParticipantsKenny Green - Investor...

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.